On the day the European Union announced the purchase of more than 100 thousand vaccines against monkeypox, the World Health Organization recommended administering the vaccine to endanger communication with health professionals or medical technician. The site is included in the interim guidelines for vaccination strategies released Tuesday.
The World Health Organization (WHO) has confirmed that universal vaccination, i.e. the entire population, is not recommended for the spread of monkeypox (monkeypox and VMX). Monitoring and control is a priority for the WHO, which also indicates the need to increase surveillance and monitoring of identified cases.
As of Tuesday, there were more than 1,500 confirmed cases in countries without the disease, bringing Portugal to 231 – remaining the country with the highest number of confirmed cases per population.
As for the vaccine strategy, which has not yet been demonstrated by Portugal, the WHO recommends dose management of second- or third -generation vaccines in relation to confirmed or suspected cases – up to four days later ‘ communication (or up to 14 days if no symptoms. development).).
In these cases, the level of risk does not vary by type of relationship. The WHO has noted that people at high or moderate risk should get the vaccine after an outbreak. Average contact involves being close to the same physical space without wearing appropriate protective equipment. High-risk contact means the spraying of water or dust from a contaminated area, direct physical contact, sexual intercourse or intercourse with contaminated equipment (such as towels, objects or clothing).
In the case of health workers or VMPX diagnostic laboratories, the vaccine is recommended as a preventive measure for all those at risk of contracting the disease. The WHO said that people “at risk of this epidemic are clinicians and laboratory staff who work with this family of viruses or do tests for the disease.”
In relation to confirmed or suspected cases, there are a priority group of VMPX vaccines: children, pregnant women and immunocompromised individuals. These at-risk groups, as defined by the WHO, are at greater risk of contracting the disease than the rest of the population. However, however, a preventive vaccine is not recommended in these cases – after contact with the same case.
The day after the first case of VMPX was announced in Portugal, the European Centers for Disease Control had already acknowledged the potential of vaccination against more risky infections, a strategy also proposed by the WHO (and expanded). Unlike the Director General of Health, national authorities in other European countries have already recommended recommendations for the VMPX vaccine, and Canada, Spain, the United States, France or the United Kingdom have already begun prescribing doses to ‘dangerous and professional relationships. health.